Theme: Pharmaceutical analysis of amide of p-aminobenzenesulfonic acid derivatives (sulfanilamides) as drug substances: synthesis, properties, analysis, storage, action and use.
Sulfanilic acid (p-aminobenzenesulphoacid)

– is substitution product –ОН group in molecule of sulphatic acid H2SO4 on rest of aniline –C6H5–NH2 . Sulfanilic acid is not drug.

–
![]() |
amide of sulfanilic acid (sulfanilamide) – is sours for synthesis many drugs.
– Structural formula of sulfanilamides:
R – radical (aliphatic or heterocyclic) in sulfamide group – SO2NH2
R1 – radical (aliphatic? aromatic or heterocyclic) in aromatic amino-group– NH2.
Sulfanilamides with antibacterial action
The term sulfanilamide is commonly used to antibacterials that are aniline-substituted sulfonamides, the “sulanilamides”; prodrugs that produce sulfanilamides (sulfasalazune); and nonanilane sulfonamides (mafenide).
Mechanism of action
Folinic acid, N5, N10-methylenetetrahydrofolic acid, and N10– formyltetrahydrofolic acid are indispensable for several biosynthetic pathways in humans, bacteria, animals and plants. Without these folate coenzymes will not available to produce nucleic acids needed for cell division. The result of any drug blocking the biosynthesis of folate coenzymes in bacteria, for example, is that growth and cell division are stopped. Such drugs – including the sulfonamides and trimethoprim – are thus bacteriostatic.
Folate coenzymes are biosynthesized from dietary folic acid in humans (and other animals). However, bacteria must make them from p-aminobensoic acid (PABA). The microbes cannot use dietary folic acid from the host, for reasons not yet completely understood. It may be that folic acid cannot penetrate the cell wall.
The sulfonamides act as competitive inhibitors for the incorporation of PABA to form dihydroptiroic acid.
General methods of synthesis sulfanilamides
For synthesis of sulfanilamides use diferents organic compounds with general formula , that is aniline derivatives C6H5–NH2, with protected amino-group –NH2.
1) Sulphonation of acetanilide by means of sulphuric chlorohydrin (sulphate-acid chloride HO–SO2–Cl) with formation acetyl sulfanilic-acid chloride:
![]() |
acetylsulfanilchloride
2) Condensation obtaining product with ammoniac NH3 or other amine R–NH2 with formationс образованием acetyl sulfanilamides:
![]() |
Medium HCl.
3) Saponification acyl group by means of boiling with mineral acids (HCl, H2SO4 – acid hydrolis) or alkali (obtained Na–salt of sulfanilamide).
Method 2. Initial substance – sulfanilic acid.
sulfanilic acid Na p-aminobenzene sulphonate acylation H2 N- group
![]() |
Na p-acetylaminobenzene sulphonate Na p-acetylaminobenzene sulphchloride
![]() |
alkyl-amide of p-N-acetylsulfanilic acid alkylsulfanilamide
Method 3 (most rational and economic). Initial substance – phosgene Cl–CO–Cl (toxic gas) and aniline C6H5NH2, by means of which synthesis carbmethoxyanilide.
![]() |
![]() |
![]() |
Chemical properties and reaction of identification
І. Amphoteric characters of sulfanilamides and its solubility in cids and alkalis
General formula of many sulfanilamides , its consists in molecule amino–group–NH2 with basic properties and substituted sulphamide–group with acid properties. Therefore many sulfanilamides
are amphoteric compounds.
а) as base its dissolves in acids with formation salts:
![]() |
HCl· .
But this salts in water very hydrolyzes and practical not exists.
b) in acid sulfanilamide-group Hydrogene-atom can substitutes on metal with formation salts. Therefore sulfanilamides can dissolutions in alkalis and carbonates of alkalis metals:
![]() |
Sulfacetamide (N-[(4-Aminophenyl)sulfonyl]-acetamide; N–sulfanylacetamide). Its plasma half-life is seven hours. This compound is a white crystalline powder, soluble in water and in alcohol. It is very soluble in hot water, and its water solution is acidic.

Sulfacetamide sodium (Sodium sulamyd)
is obtained as a monohydrate and is the white, odorless, bitter, crystalline powder that is very soluble in water. Because the sodium salt is highly soluble at the physiologic pH of 7.4, it is especially suited, as a solution, for repeated topical applications in the local management of ophthalmic infections susceptible to sulfonamide therapy.



Silver sulfadiasine (Silvedene). The silver salt of sulfadiasine applied in a water-miscible cream base has proved to be an effective topical antimicrobial agent, especially against Pseudomonas species. This is of particular significance in burn therapy because pseudomonad is often responsible for failures in therapy. The salt is only very slightly soluble and does not penetrate the cell structure. Studies using radioactive silver have shown essentially no adsorption into body fluids. Sulfadiazine levels in serum were about 0.5 to 2 mg/100 ml.

The preparation is reported to be simpler and easier to use than other standard burn treatments, such as application of freshly prepared dilute silver nitrate solutions or mafenide ointment.
Sulfanilamides are white, and odorless compounds. Only sulfapyridazine is a yellow powder and salasopyridasine is a orange powder. Sulfanilamides are slightly soluble or insoluble in water, alcohol, CHCl3, ether. Some of sulfanilamides are soluble in acetone. In practice we often use sodium salts of sulfanilamides: sulfacetamide sodium, norsulfasole sodium, aethazole sodium, sulfapyridazine sodium, which have general formula:

Sodium salts of sulfanilamides are very soluble in water and slightly soluble or insoluble in organic solvents.
Because of amphoteric properties sulfanilamides dissolve in acids and bases to form a salts.
Identification of sulfanilamides
For identification of sulfanilamides carry out general reactions characteristic of functional groups and specific reaction for each substance.
1. Diazo coupling reaction.
It is general reaction for all substances containing primary aromatic amino group. For sulfanilamides with replaced amino group (streptocide, phthazine, phthalasole) previously make hydrolysis by boiling with diluted hydrochloric acid.

2. Lignin test.
At drawing on a paper or wood of drops of a diluted hydrochloric acid and sulfanilamide there is a formation of orange-yellow coloring (lignin hydrolyzes to form aromatic aldehydes, which cooperate with primary aromatic amines).

3. Reactions of halogenation.

4. Pyrolysis of sulfanilamide. At thermal decomposition of a preparation in dry tube melts get various coloring. For example, at pyrolysis of streptocide a violet melt with odor of aniline and ammonia forms; norsulfazole gets a brown melt with odor of H2S; urosulfan – violet melt with odor of NH3.
5. Revealing
![]() |
Forming sulphate-ions SO42– revealing by means of barium chloride in the medium diluted HCl.
SO42– + Ba2+ ® BaSO4¯
white
Not dissolve in mineral acids and alkalis.
6. Reaction with solution of heavy metals.
Sulfanilamides form color complexes with solutions of cuprum, silver, cobalt and iron. For example, sulfacetamide sodium forms a blue-green precipitate with solutions of cuprum salts; norsulfazole – violet precipitate; aethazole – dirty green precipitate that goes to black; sulfadimethoxine – dirty yellow; sulfalene – dirty green precipitate that goes to green- blue; sulfadimezine – green-yellow precipitate that goes to brown; phtazine – green-blue precipitate; and salopiridazine – green precipitate.
General formula of complexes is:

![]() |
7. Reaction with sodium nitroprusside (Legalya reagent).
Solutions of sulfanilamides react with 1% solution of sodium nitroprusside Na2[Fe(CN)5NO] in presence of bases (NaOH) and following acidification to form red or red-brown solutions (streptocide, streptocide soluble, sulgine, urosulfane, sulfacetamide sodium), or precipitates (aethazole, norsulfasole, sulfadimezine).
8. UV-spectroscopy.
9. IR- spectroscopy.
ASSAY of sulfanilamides
Many methods:
1. Nitritometry, direct titration
For many sulfanilamides, if in molecules is free aromatic amino-group: стрептоцида, сульфацил–натрия, сульгина, уросульфана, норсульфазола, норсульфазол–натрия, сульфадимезина, сульфадиметоксина, сульфапиридазина и др.
Diazotization of free aromatic amino-group: 
Em = M.m.
For drugs free aromatic amino-group whis method is possible after preliminary hydrolysis:

2. Alkalimetry (direct titration) in the medium organic solvent (for drugs with acid character)
T – NaOH
Medium – alcohol or water-acetone solution
Indicator – thymolphthalein.
![]() |
Em = M.m.
3. Alkalimetry, non-aqueous titration
T – NaOH
Medium – DMFA, methanol, benzene
Indicator – thymol dark blue.
Titrate to change colour from yellow to dark blue.
![]() |
Em = M.m./2
5. Acidimetry in the presence of organic solvent (for Na-salts of sulfanilamides).
T – HCl
Medium – mix of alcohol and acid
Indicator – methyl orange.
Titrate to pink colour.
![]() |
Em = M.m.
5. Bromatometry, back titration, with iodometric finishing
Aliquot of test solution add in flask, add excess of standard solution of potassium bromate КBrO3, crystalline potassium bromide KBr, acidifies by means of HCl (or H2SO4), stand 15 minutes, stir up.
KBrO3 + 5KBr + 6HCl = 3Br2 + 6KCl + 3H2O
Allocated bromine Br2 react with drug (reaction for benzene ring) with formation dibromoderivative:
Add solution of potassium iodide KI. Not reacted bromine Br2 react with potassium iodide KI with formation iodine I2:
Br2 + 2KI = I2 + 2KBr
Allocated iodine I2 titrate with standard solution of sodium thiosulphate Na2S2O3. As indicator use starch solution and titrate to dissapperance dark blue colouring (add starch solution in the end titration):
I2 + 2Na2S2O3 = 2NaI + Na2S4O6
I2 + 2е ® 2I–
2S2O32– – 2е ® S4O62–
Carry out a control titration.
Еm = М. m./4
6. Iodochlorometry, back titration
To test solution add excess standard solution of iodomonochloride ICl, which react with drug (iodination of benzene ring in free о–positions rather (of) Н2N–group):
Not reacted ICl react with potassium iodide KI with formation iodine I2, which titrate with standard solution of Na2S2O3 (indicator – starch solution).
ICl + KI = I2 + KCl
I2 + 2Na2S2O3 = 2NaI + Na2S4O6
Carry out a control titration.
Еm = М.m./4
7. Argentometry, Morh method
Some sulfanilamides (for example, sulfathiazole) forming salts at titration by means of standard solution of AgNO3 (acid properties of sulfamide group –SO2–
In the Morh method is necessary neutral medium. Formed nitric acid HNO3 will be promote dissolution Ag-salt (displacement reaction to the left). Therefore titrate in the presence of borax Na2B4O7×10Н2О, which neutralised HNO3:
Na2B4O7 + 2HNO3 + 5Н2О = 4H3BO3 + 2NaNO3
As indicator use solution of potassium chromate K2CrО4. Titrate to orange-red precipitate: excess drop of titrant AgNO3 react with indicator K2CrО4 with formation precipitate Ag2CrО4:
2AgNO3 + K2CrО4 ®Ag2CrО4¯ + 2КNO3
orange-red precipitate
Еm = М. m.
8. Coppermetry
To solution of Na-salt sulfanilamide add solution of copper sulphate CuSO4 (not standard solution) and sodium hydroxide NaOH.
![]() |
Add solution of sulphatic acid H2SO4, which destroys complex and frees equivalent quantity CuSO4. After that add solution of potassium iodide KI:
2CuSO4 + 4KI ® Cu2I2 + I2 + 2K2SO4
Allocated iodine I2 titrate with standard solution of sodium thiosulphate Na2S2O3. As indicator use starch solution and titrate to dissapperance dark blue colouring (add starch solution in the end titration):
I2 + 2Na2S2O3 = 2NaI + Na2S4O6
Em = 2М.m.
9. Gravimetry after mineralization of preparation
At mineralization of sulfanilamide preparation by means of concentrated nitric acid HNO3 or melts with 10-multiple quantity of potassium nitrate KNO3 Sulphur passes into sulphate-ions SO42–.
![]() |
Their quantity precipitates by means of soluble barium salt – ВаCl2:
SO42– + Ba2+ → BaSO4↓
Precipitate BaSO4 filteres, dry up, incinerates (calcinates) to constant weight (mass) and weighs. By means of mass of BaSO4 calculate % maintenance of sulfanilamide preparation.
10. Keldal method (classic) – definition of Nitrogen in the preparation.
Substance of drug mineralizated by means of boiling in the special instrument at presence of K2SO4, CuSO4 and concentrated H2SO4. Nitroge passes into ammonium hydrosulphate NH4HSO4, which at interaction with alkali NaOH formed ammonia NH3:
NH4HSO4 + 2NaOH ® NH3 + Na2SO4 + 2H2O
Allocated ammonia NH3 distilates into flask-receiver (collector) with boric acid H3BO3:
NH3 + H3BO3 ® NH4BO2 + H2O
2NH3 + 4H3BO3 ® (NH4)2B4O7 + 5H2O
Formed salts (metaborate NH4BO2 and tetraborate ammonium (NH4)2B4O7) titrate with standard solution of HCl in the presence of mix indicators (mix of methyl red and methylene dark blue (2:1)):
NH4BO2 + HCl + H2O ® NH4Cl + H3BO3
(NH4)2B4O7 + 2HCl + 5H2O ® 2NH4Cl + 4H3BO3
Em of preparation depended of figure atoms of Nitrogen in the substance molecule.
11. Colourimetry
Method based on synthesis colored products diferents reactions (azo dyes, complex with heavy metals and other).
12. Spectrofotometry in UV- or visible spectral range.
Storage. List of strong substance. In dense corked containers, at protecting from light, a dry and cool place.
Action and use. Chemiotherapeutic antibacterial agents.
Table 1
![]() |
Classification, structure and chemical names of sulfanilamides preparations
|
№ |
Drug |
Radical R (in sulfamide group) |
Radical R1 (in aromatic amino group) |
The formula and the chemical name of drug |
Use and preparations |
|
|
Aliphatic (R) derivatives |
||||||
|
|
Sulfanilamide* Streptocide
|
– |
– |
p-Aminobenzene sulfonamide
|
Various infectious diseases. Powder, tablets ( |
|
|
|
Streptocide soluble Streptocidum solubile |
– |
–CH2SO3Na |
Sodium p-sulfamidobenzolamino methylenesulphonate |
Powder, 1–1,5 % intramuscular and subcutaneous injections; 2–5–10 % intravenous injections; 5 % linimentum; The combined drug – Inhalyptum. |
|
|
|
Sulfacetamide sodium Sulfacetamidum natricum* Albucid-sodium
|
The rest sodium-acetamide hydrate |
– |
Sodiump-aminobenzolsulphonylacetamide hydrate |
Various eyes diseases. Powder, 10–20–30 % solutions (eyes drops); 30 % injection solution; 10–20–30 % eyes ointments. |
|
|
|
Sulfaguanidine* Sulgine
|
The rest guanidine hydrate |
– |
(4-aminophenylsulphonyl)guanidine or
p-Aminobenzolsulphonylguanidine hydrate |
Intestinal infections. Powder, tablets ( |
|
|
|
Sulfacarbamide Urosulfanum
|
The rest of urea hydrate |
– |
p-Aminobenzolsulphonyurea hydrate |
At infections of urethras (uric ways) such as cystitis, pyelitis, pyelonephritises (tablets – |
|
|
Heterocyclic (R) derivatives |
||||||
|
|
Sulfathiazole* Norsulfazole
|
Thiazole cycle
|
– |
2 (p-Aminobenzolsulfamide)-thiazole |
Pneumonia, meningitis, sepsis, dysentery, etc. Powder, tablets ( |
|
|
7.
|
Norsulfazole sodium Sulfathiazolum natricum* |
|
– |
Sodium 2 (p-aminobenzolsulfamide)-thiazole |
At blephatitis, conjuctives; the combined drug – Inhalyptum. 5 % and 10 % intravenous injections, 10 % eyes drops. |
|
|
|
Sulfadiazine, sulfanilamidopyrimidine
|
Pyrimidine |
–
|
2 (p-Aminobenzolsulfamide)-pyrimidine |
Dysentery, malaria. Powder, tablets ( |
|
|
|
Silver salt of Sulfadiazine |
Pyrimidine cycle |
– |
Silver salt 2 (p-aminobenzolsulfamide)-pyrimidine |
Bactericidal action. 1 % ointment for treatment wound and burn tissues. |
|
|
|
Sulfadimezine, Sulfadimidine* |
Pyrimidine cycle |
– |
2 (p-Aminobenzolsulfamide)-4,6-dimethylpyrimidine |
At various coccal infections, sepsis, gonorrhoea, dysentery. Powder, tablets ( |
|
|
|
Etazole, Sulfaethidole*, Etazolum |
1,3,4-Thiadiazole cycle |
– |
2 (p-Aminobenzolsulfamide)-5-ethyl-1,3,4-thiadiazole |
Pneumonia, dysentery, pyelites, cystitis, wound infections, etc. Powder, tablets ( |
|
|
12.
|
Etazole sodium, Sulfaethidolum natricum* Aethazolum solubile |
1,3,4
Thiadiazole cycle |
– |
Sodium 2 (p-Aminobenzolsulfamide)-5-ethyl-1,3,4-thiadiazole |
Pneumonia, dysentery, pyelites, cystitis, wound infections, etc.10 % and 20 % intravenous injections (slowly); granules for children. |
|
|
|
Sulfalene, Sulfalenum |
Pyrazine cycle |
– |
2 (p-Aminobenzolsulfamide)-3-metoxypyrazine |
Infections of respiratory organs, biliferous and urinary ways. Tablets ( |
|
|
|
Sulfapyridazine Sulfamethoxypyridazine* |
Pyridazine cycle |
– |
6 (p-Aminobenzolsulfamide)-3-methoxypyridazine |
For treatment and preventive maintenance (prophylactics) of purulent surgical infections, etc.(long action). Powder, tablets ( |
|
|
15.
|
Sulfapyridazine sodium, Sulfapyridazinum-natrium |
Pyridazine cycle |
– |
Sodium 6 (p-aminobenzolsulfamide)-3-methoxypyridazine tetrahydrate |
At local purulent infection for spraying of wounds in the form of bandages from 3–5–10 % solutions; 10 % and 20 % eyes drops for trachoma treatment, eyes membranulas. |
|
|
|
Sulfamonomethoxine, Sulfamonomethoxinum |
Pyrimidine cycle |
–
|
6 (p-Aminobenzolsulfamide)-4-methoxypyrimidine |
|
|
|
|
Sulfadimethoxine, Madribonum |
Pyrimidine cycle |
– |
6 (p-Aminobenzolsulfamide)-2,4-dimethoxypyrimidine |
Sulfanilamide a long action; used at many infections. |
|
|
Heterocyclic (R) derivative and aromatic, heterocyclic (R1) derivatives |
||||||
|
|
Phthalylsulfathiazole* Phthalazole, Sulphothalidine,
|
Thiazole cycle |
The rest of phthalic acid (phthalyl-) |
2 (p-Phthalylaminobenzolsulfamide)-thiazole |
At intestinal infections (dysentery, colitises, coloenterites), at operations on intestines. Powder, tablets ( |
|
|
|
Phthazine, Phthazinum |
Pyridazine cycle |
The rest of phthalic acid (phthalyl-) |
6(p-Phthalylaminobenzolsulfamide)-3-methoxypyridazine |
At heavy forms of dysentery, colitises coloenterites. Powder, tablets ( |
|
|
|
Salazopyridazine Salazodine* |
Pyridazine cycle |
The rest of 5-aminosalicylicacid |
5 (p – [N – (3-methoxypyridazinyl-6)-sulfamide]-phenylazo)-salicylic acid |
Decays in intestines to sulfapyridazine and 5-aminosalicylic acid. For treatment nonspecific ulcer colitis and Crone illness in the form of 5 % suspension and tablets ( |
|
|
|
Salazodimethoxine, Salazodimethoxinum |
Pyrimidine cycle |
The rest of 5-aminosalicylic acid |
5 {p – [(2,4-dimethoxypyrimidinyl-6)-sulfamide]-phenylazo}-salicylic acid |
At intestinal infections. Decays in intestines to Sulfadimethoxine and 5-aminosalitcylic acid. Tablets (after meal) ( |
|
|
|
Bactrimum Biseptol Co-Trimoxazolle* |
The combined drug
Sulfamethoxazole (bacteriostatic action) 3 (p-Aminobenzolsulfamide)-5-methylizoxazole
Trimethoprimum (bacteriostatic action) 2,4-diamino-5 (3,4,5-trimethoxybenzil)-pyrimidine |
Double blocking of metabolism of bacteria: Sulfamethoxazole breaks biosynthesis dihydrofolic acid, and Trimethoprimum blocks the next stage – reduction of dihydrofolic acids in tetrahydrofolic acid. Tablets Biseptol-480 (Poland). |
|||
Table 2
Properties, reactions of identification and methods of assay of some sulfanilamides |
|||||
|
№ |
Drug
|
The chemical formula and analytic-functional groups |
Properties (the appearance and solubility), specific impurities |
Reactions of identification |
Methods of assay |
|
|
Streptocide |
|
White, crystalline powder.
Slightly soluble in cool water, freely soluble in hot water. |
1. Reaction of formations azo dye. 2. Pyrolysis п fusion (melt) blue-violet colour, a smell of ammonia NH3 and aniline. |
1. Nitritometry Еm = M. m. 2. Photocolorimetry3.Bromatometry Еm = M.m./4 4.Iodo–chlormetry Еm = M.m./4 |
|
|
Streptocide soluble |
|
White, crystalline powder.
Soluble in water, practically insoluble in ether and chloroform. |
1. Reaction of formations azo dye only after alkaline hydrolysis. 2. Hydrolysis with the next revealing SO2 and HCHO 3. Reactions for Na +-ions. |
1. Acidimetry in the presence of organic dissolvent Еm = M. m. 2. Nitritometry after alkaline hydrolysis Еm = m. M. |
|
|
Sulfatsil-sodium |
|
White, crystalline powder.
Freely soluble in water, practically insoluble in organic dissolvents. Specific impurity – sodium sulphite Na2SO3 (Define by means of iodometry) |
1. Reaction of formations azo dye. 2. With CuSO4 – precipitate of dark blue-green colour is formed. 3. Reactions for Na +-ions. 4. Acid hydrolysis of drug with the next revealing СН3СООН .
|
1. Nitritometry Еm = M. m. 2. Acidimetry in the presence of organic dissolvent Еm = M. m. |
|
|
Sulgine |
|
White, fine-crystalline powder.
Very slightly soluble in water, organic dissolvents and alkalis (unlike urosulfanum (sulfacarbamide)) |
1. Reaction of formations azo dye. 2. Pyrolysis п fusion (melt) violet-red colour, a smell of ammonia NH3. 3. Reaction Sakaguchy: With a-naphthol in the medium of NaOH, Br2 or NaBrO ®naphthoquinonimine of red-violet colour is formed. 4. Pyrolysis of drug NNH3 |
1. Nitritometry and other metods. Еm = M. m. |
|
|
Urosulfanum (sulfacarbamide) |
The urea rest |
White, crystalline powder.
Slightly soluble in water, alcohols, freely soluble in acetone, diluted acids and alkalis. |
1. Pyrolysis п fusion (melt) violet-red colour, a smell of ammonia NH3. 2. Reaction with NaOH ® NH3 (urea decomposition) 3. With solution of NaNO2 at heating rubinovo-krasn red colour (Difference from sulgine and other sulfanilamides).
|
1. Nitritometry and other metods. Еm = M. m. |
|
|
Norsulfazole |
|
White, sometimes with yellowish shade powder.
Very slightly soluble in water and organic dissolvents, soluble in acids and alkalis. |
1. Reaction of formations azo dye. 2. Pyrolysis п fusion (melt) of dark-brown colour, smell H2S (heterocyclic 3. With CuSO4 – precipitate of violet colour is formed. 4. With CоCl2 – precipitate of lilac colour untidily-fiol violet colour is formed. |
1. Nitritometry Еm = M. m. 2.Argentometry Еm = M. m. 3. Alkalimetry in the water-acetone solution or in the alcohol. Еm = M. m. |
|
7.
|
Sulphathiazole sodium (Norsulfazole-sodium) |
|
Lamellar, brilliant, colourless crystals. Freely soluble in water. |
1. Reaction of formations azo dye. 2. Pyrolysis п fusion (melt) of dark-brown colour, smell H2S (heterocyclic 3. With CuSO4 – precipitate of violet colour is formed. 4. With CоCl2 – precipitate of lilac colour untidily-fiol violet colour is formed. 5. Reactions for Na +-ions.
|
1. Nitritometry Еm = M. m. 2. Acidimetry in the presence of organic dissolvent Еm = M. m. |
|
|
Sulfadimezine |
|
White, or with yellowish shade powder.
Practically insoluble in water, slightly soluble in alcohol, practically insoluble in other organic dissolvents, freely soluble in acids and alkalis. |
1. Reaction of formations azo dye. 2. With CuSO4 – precipitate of yellowish-green colours the brown brown colour is formed. 3. With Legalya reagent (solution oxidised sodium nitroprusside Na2 [Fe (CN)5NO]) фviolet colouring.
|
1.Nitritometry and other metods. Еm = M. m. |
|
|
Sulfadimethoxine |
|
White, sometimes with yellowish shade powder.
Practically insoluble in water, slightly soluble in alcohol, freely soluble diluted HCl and alkalis. |
1. Reaction of formations azo dye. 2. With CuSO4 – amorphous precipitate of yellow-green colour is formed. 3. With CоCl2 – precipitate of bright-pink colour with a lilac shade is formed. |
1.Nitritometry and other metods. Еm = M. m. |
|
10.
|
Phthalazole, sulphothalidine |
|
White, sometimes with yellowish shade powder.
Practically insoluble in water, ether and chloroform, very slightly soluble in alcohol, soluble in solutions of alkalis and carbonates of alkaline metals.
Specific impurity – phthalic acid (define by means of alcalimetry); – norsulfazole (define by means of nitritometry). |
1. It is not dissolved in acids. 2. Reaction of formations azo dye only after acid hydrolysis. 3. Reaction of formations fluoresceine after acid hydrolysis (for phthalic acid) green green fluorescence. |
1. Alkalimetry, non-aqueous titration Еm = M.m./2 |
|
|
Salazodimethoxinum |
|
Brownish-orange fine-crystalline powder.
Practically insoluble in water, ether and chloroform, very slightly soluble in alcohol, soluble in solutions of alkalis and carbonates of alkaline metals. |
1. Reaction of formations azo dye only after hydrolysis. 2. Reaction with solution of FeCl3 (for phenolic hydroxyl) sine-fiol blue-violet Colouring. 3. Reaction with salts of heavy metals (for groups –СООН и –SO2–NH–). |
1. Nitritometry after hydrolysis Еm = M.m./2 2. Alkalimetry in the presence of organic dissolvent Еm = M.m./ 2 3. Method Keldalya Еm = M.m./5
|
|
12.
|
Bactrimum
Co-trimoksazol
Biseptol |
|
|
1. Melting point 169–172 °C. 2. IR-spectroscopy 3. Thin layer chromatography 4. Formation azo dye.
1. Melting point 199–203 °C. 2. IR-spectroscopy 3. Uf-spectroscopy 4. With solution of KMnO4 + H2SO4 at heating + HCHO + H2SO4 heating + methylene chloride green green fluorescence
|
1.Nitritometry and other metods. Еm = M. m. 2. Method Keldalya Еm = M.m./4 3. Alkalimetry in the presence of organic dissolvent Еm = M. m.
|
Sulfanilamide
General Notices
(Ph Eur monograph 1571)
Pantosil album

C6H8N2O2S 172.2 63-74-1
Action and use
Antibacterial.
Ph Eur
DEFINITION
Sulfanilamide contains not less than 99.0 per cent and not more than the equivalent of 101.0 per cent of 4-aminobenzenesulphonamide, calculated with reference to the dried substance.
CHARACTERS
White or yellowish-white crystals or fine powder, slightly soluble in water, freely soluble in acetone, sparingly soluble in alcohol, practically insoluble in methylene chloride. It dissolves in solutions of alkali hydroxides and in dilute mineral acids.
IDENTIFICATION
First identification B.
Second identification A, C, D.
A. Melting point (2.2.14):
B. Examine by infrared absorption spectrophotometry (2.2.24), comparing with the spectrum obtained with sulfanilamide CRS. Examine the substances prepared as discs.
C. Examine the chromatograms obtained in the test for related substances. The principal spot in the chromatogram obtained with test solution (a) is similar in position and size to the principal spot in the chromatogram obtained with reference solution (a).
D. Dissolve about 5 mg in 10 ml of
TESTS
Solution S
To
Acidity
To 20 ml of solution S add 0.1 ml of bromothymol blue solution R1. Not more than 0.2 ml of
Related substances
Examine by thin-layer chromatography (2.2.27), using a TLC silica gel F 254plate R.
Test solution (a) Dissolve 20 mg of the substance to be examined in 3 ml of a mixture of 2 volumes of concentrated ammonia R and 48 volumes of methanol R and dilute to 5 ml with the same mixture of solvents.
Test solution (b) Dissolve
Reference solution (a) Dissolve 20 mg of sulfanilamide CRS in 3 ml of a mixture of 2 volumes of concentrated ammonia R and 48 volumes of methanol R and dilute to 5 ml with the same mixture of solvents.
Reference solution (b) Dilute 1.25 ml of test solution (a) to 50 ml with a mixture of 2 volumes of concentrated ammonia R and 48 volumes of methanol R.
Reference solution (c) Dissolve 20 mg of the substance to be examined and 20 mg of sulfamerazine CRS in 3 ml of a mixture of 2 volumes of concentrated ammonia R and 48 volumes of methanol R and dilute to 5 ml with the same mixture of solvents.
Apply to the plate 5 µl of each solution. Develop over a path corresponding to two-thirds of the plate height using a mixture of 3 volumes of dilute ammonia R1, 5 volumes of water R, 40 volumes of nitromethane R and 50 volumes of dioxan R. Dry the plate at
Heavy metals (2.4.8)
12 ml of solution S complies with limit test A for heavy metals (20 ppm). Prepare the standard using lead standard solution (1 ppm Pb) R.
Loss on drying (2.2.32)
Not more than 0.5 per cent, determined on
Sulphated ash (2.4.14)
Not more than 0.1 per cent, determined on
ASSAY
Carry out the determination of primary aromatic amino-nitrogen (2.5.8), using
(2.5.8): Dissolve the prescribed quantity of the substance to be examined in 50 ml of dilute hydrochloric acid R or in another prescribed solvent and add
Determine the end-point electrometrically or by the use of the prescribed indicator.
1 ml of
STORAGE
Store protected from light.
Ph Eur
Sulfacetamide sodium
General Notices
Soluble Sulfacetamide
(Ph Eur monograph 0107)

C8H9N2NaO3S,H2O 254.2 6209-17-2
Action and use
Antibacterial.
Ph Eur
DEFINITION
Sulfacetamide sodium contains not less than 99.0 per cent and not more than the equivalent of 101.0 per cent of the sodium derivative of N-[(4-aminophenyl)sulphonyl]acetamide, calculated with reference to the anhydrous substance.
CHARACTERS
A white or yellowish-white, crystalline powder, freely soluble in water, slightly soluble in ethanol.
IDENTIFICATION
First identification B, F.
Second identification A, C, D, E, F.
A. Dissolve
B. Examine by infrared absorption spectrophotometry (2.2.24), comparing with the spectrum obtained with sulfacetamide sodium CRS.
C. Dissolve
D. Dissolve
E. Dissolve about 1 mg of the precipitate obtained in identification test C, with heating, in 1 ml of water R. The solution gives the reaction of primary aromatic amines (2.3.1) with formation of an orange-red precipitate.
F. Solution S (see Tests) gives the reactions of sodium (2.3.1).
TESTS
Solution S
Dissolve
Appearance of solution
Solution S is clear (2.2.1) and not more intensely coloured than reference solution GY4 (2.2.2, Method II).
pH (2.2.3)
The pH of solution S is 8.0 to 9.5.
Related substances
Examine by thin-layer chromatography (2.2.27), using silica gel HF254 R as the coating substance.
Test solution Dissolve
Reference solution (a) Dissolve 5 mg of sulfanilamide R in water R and dilute to 10 ml with the same solvent.
Reference solution (b) Dilute 5 ml of reference solution (a) to 10 ml with water R.
Reference solution (c) Dissolve 5 mg of sulfanilamide R in 10 ml of the test solution.
Apply to the plate 5 µl of each solution. Develop over a path of
Sulphates (2.4.13)
Dissolve
Heavy metals (2.4.8)
12 ml of the filtrate obtained in the test for sulphates complies with limit test A for heavy metals (20 ppm). Prepare the standard using lead standard solution (1 ppm Pb) R.
Water (2.5.12)
6.0 per cent to 8.0 per cent, determined on
ASSAY
Dissolve
1 ml of
STORAGE
Store protected from light.
Ph Eur
Sulfathiazole
norsulfazole (sulfathiazole)
General Notices
(Ph Eur monograph 0742)

C9H9N3O2S2 255.3 72-14-0
Action and use
Antibacterial.
Ph Eur
DEFINITION
Sulfathiazole contains not less than 99.0 per cent and not more than the equivalent of 101.0 per cent of 4-amino-N-(thiazol-2-yl)benzenesulphonamide, calculated with reference to the dried substance.
CHARACTERS
A white or slightly yellowish, crystalline powder, practically insoluble in water, slightly soluble in alcohol, practically insoluble in methylene chloride. It dissolves in dilute solutions of alkali hydroxides and in dilute mineral acids.
IDENTIFICATION
First identification A, B.
Second identification A, C, D, E.
A. Melting point (2.2.14):
B. Examine by infrared absorption spectrophotometry (2.2.24), comparing with the spectrum obtained with sulfathiazole CRS. Examine the substances prepared as discs. If the spectra obtained show differences, dissolve the substance to be examined and the reference substance separately in alcohol R, evaporate to dryness in vacuo and record the spectra again using the residues.
C. Examine the chromatograms obtained in the test for related substances. The principal spot in the chromatogram obtained with test solution (b) is similar in position, colour and size to the principal spot in the chromatogram obtained with reference solution (a).
D. Dissolve about 10 mg in a mixture of 10 ml of water R and 2 ml of
E. Dissolve about 5 mg in 10 ml of
TESTS
Appearance of solution
Dissolve
Acidity
To
Related substances
Examine by thin-layer chromatography (2.2.27), using silica gel H R as the coating substance.
Test solution (a) Dissolve
Test solution (b) Dilute 1 ml of test solution (a) to 5 ml with a mixture of 1 volume of concentrated ammonia R and 9 volumes of alcohol R.
Reference solution (a) Dissolve 20 mg of sulfathiazole CRS in a mixture of 1 volume of concentrated ammonia R and 9 volumes of alcohol R and dilute to 10 ml with the same mixture of solvents.
Reference solution (b) Dissolve 50 mg of sulfanilamide R in a mixture of 1 volume of concentrated ammonia R and 9 volumes of alcohol R and dilute to 100 ml with the same mixture of solvents. Dilute 1 ml of this solution to 10 ml with the same mixture of solvents.
Apply to the plate 10 µl of each solution. Develop over a path of
Heavy metals (2.4.8)
Loss on drying (2.2.32)
Not more than 0.5 per cent, determined on
Sulphated ash (2.4.14)
Not more than 0.1 per cent, determined on
ASSAY
Carry out the determination of primary aromatic amino- nitrogen (2.5.8), using 0.200 g, determining the end-point electrometrically.
1 ml of
STORAGE
Store protected from light.
Ph Eur
Sulfathiazole Sodium
General Notices

C9H8N3NaO2S2,1ЅH2O 304.3 144-74-1(anhydrous
C9H8N3NaO2S2,5H2O 367.4 6791-71-5
Action and use
Antibacterial.
Preparation
Tylosin Tartrate and Sulfathiazole Sodium Veterinary Oral Powder
DEFINITION
Sulfathiazole Sodium is the hydrated sodium salt of N1-thiazol-2-yl sulphanilamide, either the sesquihydrate or the pentahydrate. It contains not less than 99.0% and not more than 101.0% of C9H8N3NaO2S2, calculated with reference to the dried substance.
CHARACTERISTICS
A white or yellowish white, crystalline powder or granules.
Freely soluble in water ; soluble in ethanol (96%).
IDENTIFICATION
A. The infrared absorption spectrum of the dried substance, Appendix II A, is concordant with the reference spectrum of sulfathiazole sodium (RSV 42).
B. Dissolve
C. The precipitate obtained in test B yields the reaction characteristic of primary aromatic amines, Appendix VI, giving an orange-red precipitate.
TESTS
Alkalinity
pH of a solution containing the equivalent of 1.0% w/v of the anhydrous substance, 9.0 to 10.0, Appendix V L.
Heavy metals
Dissolve a quantity containing the equivalent of
Related substances
Carry out the method for thin-layer chromatography, Appendix III A, using silica gel H as the coating substance and a mixture of 18 volumes of 10M ammonia and 90 volumes of butan-1-ol as the mobile phase. Apply separately to the plate 10 µl of each of two solutions in a mixture of 1 volume of 13.5M ammonia and 9 volumes of ethanol (96%) containing (1) 1.0% w/v of the substance being examined and (2) 0.0050% w/v of sulfanilamide. After removal of the plate, heat it at 105° for 10 minutes and spray with a 0.1% w/v solution of 4-dimethylaminobenzaldehyde in ethanol (96%) containing 1% v/v of hydrochloric acid. Any secondary spot in the chromatogram obtained with solution (1) is not more intense than the spot in the chromatogram obtained with solution (2) (0.5%).
Loss on drying
When dried to constant weight at 105°, loses not less than 6.0% and not more than 10.0% of its weight (sesquihydrate) or not less than 22.0% and not more than 27.0% of its weight (pentahydrate).
ASSAY
Dissolve
STORAGE
Sulfathiazole Sodium should be protected from light.
LABELLING
The label states whether the substance is the sesquihydrate or the pentahydrate.
Tylosin tartrate and Sulfathiazole Sodium veterinary oral powder
General Notices
DEFINITION
Tylosin Tartrate and Sulfathiazole Sodium Veterinary Oral Powder is a mixture of Tylosin Tartrate and Sulfathiazole Sodium. The proportions of the mixture are such that the ratio of tylosin to Sulfathiazole Sodium is about one to three.
The veterinary oral powder complies with the requirements stated under Veterinary Oral Powders and with the following requirements.
Content of sulfathiazole sodium, C9H8NaO2S2,1ЅH2O
90.0 to 110.0% of the stated amount, calculated as sulfathiaziole sodium sesquihydrate.
IDENTIFICATION
A. Triturate a quantity of the powder containing the equivalent of
B. Dry the chloroform-insoluble residue reserved in test A at 105° for 1 hour. The infrared absorption spectrum of the dried residue, Appendix II A, is concordant with the reference spectrum of sulfathiazole sodium (RSV 42).
TESTS
Composition
Carry out the method for liquid chromatography, Appendix III D, using the following solutions prepared immediately before use. Solution (1) contains 0.02% w/v of tylosin BPCRS in a mixture of equal volumes of water and acetonitrile. For solution (2) dissolve the powder in a mixture of equal volumes of water and acetonitrile to produce a solution containing the equivalent of 0.02% of tylosin.
The chromatographic procedure may be carried out using (a) a stainless steel column (
The chromatogram obtained with solution (1) shows similar resolution to the reference chromatogram supplied with tylosin BPCRS. If necessary adjust the molarity of the sodium perchlorate or raise the temperature of the column to a maximum of 50°. The order of elution of the six major components of tylosin BPCRS in the chromatogram obtained with solution (1) is desmycinosyltylosin, tylosin C, tylosin B, tylosin D, an aldol impurity and tylosin A.
The column efficiency, determined using the peak due to tylosin A in solution (1), should be at least 22,000 theoretical plates per metre.
Calculate the percentage content of components by normalisation. In the chromatogram obtained with solution (2) the content of tylosin A is not less than 80% and the total content of tylosins A, B, C and D is not less than 95%. A peak due to sulphathiazole will be observed eluting immediately after the solvent peak and should be disregarded.
Related substances
Carry out the method for thin-layer chromatography, Appendix III A, using silica gel H as the coating substance and a mixture of 18 volumes of 10M ammonia and 90 volumes of butan-1-ol as the mobile phase. Apply separately to the plate 10 µl of each of the following solutions. For solution (1) shake a quantity of the powder containing
ASSAY
For tylosin activity
Transfer a quantity of the powder containing the equivalent of
For sulfathiazole sodium
Dissolve a quantity of the powder containing the equivalent of
LABELLING
The label states the quantity of Tylosin Tartrate in terms of the equivalent amount of tylosin and the quantity of Sulfathiazole Sodium in terms of the equivalent amount of sulfathiazole sodium sesquihydrate.
Phthalylsulfathiazole
(Ph Eur monograph 0352)

C17H13N3O5S2 403.4 85-73-4
Action and use
Antibacterial.
Ph Eur
DEFINITION
Phthalylsulfathiazole contains not less than 98.5 per cent and not more than the equivalent of 101.5 per cent of 2-[[4-(thiazol-2-ylsulphamoyl)phenyl]carbamoyl]benzoic acid, calculated with reference to the dried substance.
CHARACTERS
A white or yellowish-white, crystalline powder, practically insoluble in water, freely soluble in dimethylformamide, slightly soluble in acetone and in alcohol.
IDENTIFICATION
First identification A, B, E.
Second identification B, C, D, E.
A. Examine by infrared absorption spectrophotometry (2.2.24), comparing with the spectrum obtained with phthalylsulfathiazole CRS.
B. To
C. To
D. To
E. Dissolve about 10 mg of the crystals obtained in identification test B in 200 ml of
TESTS
Appearance of solution
Dissolve
Acidity
To
Sulfathiazole and other primary aromatic amines
Dissolve 5 mg in a mixture of 3.5 ml of water R, 6 ml of dilute hydrochloric acid R and 25 ml of alcohol R, previously cooled to
Heavy metals (2.4.8)
Loss on drying (2.2.32)
Not more than 2 per cent, determined on
Sulphated ash (2.4.14)
Not more than 0.1 per cent, determined on
ASSAY
Dissolve
1 ml of
STORAGE
Store protected from light.
Ph Eur
Sulfaguanidine
General Notices
(Ph Eur monograph 1476)

C7H10N4O2S 214.3 56-67-0
Action and use
Antibacterial.
Ph Eur
DEFINITION
Sulfaguanidine contains not less than 99.0 per cent and not more than the equivalent of 101.0 per cent of (4-aminophenylsulphonyl)guanidine, calculated with reference to the dried substance.
CHARACTERS
A white or almost white, fine crystalline powder, very slightly soluble in water, slightly soluble in acetone, very slightly soluble in ethanol (96 per cent), practically insoluble in methylene chloride. It dissolves in dilute solutions of mineral acids.
IDENTIFICATION
First identification A, B.
Second identification A, C, D, E.
A. Melting point (2.2.14):
B. Examine by infrared absorption spectrophotometry (2.2.24), comparing with the spectrum obtained with sulfaguanidine CRS.
C. Examine the chromatograms obtained in the test for related substances. The principal spot in the chromatogram obtained with test solution (b) is similar in position and size to the principal spot in the chromatogram obtained with reference solution (a).
D. Dissolve about 5 mg in 10 ml of
E. Suspend
TESTS
Solution S
To
Acidity
To 20 ml of solution S, add 0.1 ml of bromothymol blue solution R1. Not more than 0.2 ml of
Related substances
Examine by thin layer chromatography (2.2.27), using a TLC silica gel GF254plate R.
Test solution (a) Dissolve 50 mg of the substance to be examined in acetone R and dilute to 5 ml with the same solvent.
Test solution (b) Dilute 2 ml of test solution (a) to 10 ml with acetone R.
Reference solution (a) Dissolve 10 mg of sulfaguanidine CRS in acetone R and dilute to 5 ml with the same solvent.
Reference solution (b) Dilute 5 ml of test solution (b) to 200 ml with acetone R.
Reference solution (c) Dilute 5 ml of reference solution (b) to 10 ml with acetone R.
Reference solution (d) Dissolve 10 mg of sulfanilamide R in test solution (b) and dilute to 5 ml with the same solution.
Apply to the plate 10 µl of each solution. Develop over a path of
Heavy metals (2.4.8)
Loss on drying (2.2.32)
Not more than 8.0 per cent, determined on
Sulphated ash (2.4.14)
Not more than 0.1 per cent, determined on
ASSAY
Dissolve
1 ml of
STORAGE
Store protected from light.
IMPURITIES

A. R = H: 4-aminobenzenesulphonamide (sulphanilamide),
B. R = CO-NH2: N-[(4-aminophenyl)sulphonyl]urea (sulphacarbamide).
Ph Eur
Sulfadimidine
General Notices
(Ph Eur monograph 0295)

C12H14N4O2S 278.3 57-68-1
Action and use
Antibacterial.
Preparation
Sulfadimidine Injection
Sulfadimidine Tablets
Ph Eur
DEFINITION
Sulfadimidine contains not less than 99.0 per cent and not more than the equivalent of 101.0 per cent of 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulphonamide, calculated with reference to the dried substance.
CHARACTERS
White or almost white powder or crystals, very slightly soluble in water, soluble in acetone, slightly soluble in alcohol. It dissolves in solutions of alkali hydroxides and in dilute mineral acids.
It melts at about
IDENTIFICATION
First identification A, B.
Second identification B, C, D.
A. Examine by infrared absorption spectrophotometry (2.2.24), comparing with the spectrum obtained with sulfadimidine CRS. Examine the substances prepared as discs.
B. Examine the chromatograms obtained in the test for related substances. The principal spot in the chromatogram obtained with test solution (a) corresponds in position and size to the principal spot in the chromatogram obtained with reference solution (a).
C. Place
D. Dissolve about 5 mg in 10 ml of
TESTS
Appearance of solution
Dissolve
Acidity
To
Related substances
Examine by thin-layer chromatography (2.2.27), using silica gel GF254 R as the coating substance.
Test solution (a) Dissolve 20 mg of the substance to be examined in 3 ml of a mixture of 2 volumes of concentrated ammonia R and 48 volumes of methanol R and dilute to 5.0 ml with the same mixture of solvents.
Test solution (b) Dissolve
Reference solution (a) Dissolve 20 mg of sulfadimidine CRS in 3 ml of a mixture of 2 volumes of concentrated ammonia R and 48 volumes of methanol R and dilute to 5.0 ml with the same mixture of solvents.
Reference solution (b) Dilute 1.25 ml of test solution (a) to 50 ml with a mixture of 2 volumes of concentrated ammonia R and 48 volumes of methanol R.
Apply to the plate 5 µl of each solution. Develop over a path of
Heavy metals (2.4.8)
Loss on drying (2.2.32)
Not more than 0.5 per cent, determined on
Sulphated ash (2.4.14)
Not more than 0.1 per cent, determined on
ASSAY
Dissolve
1 ml of
STORAGE
Store protected from light.
Ph Eur
Sulfadimidine Injection
DEFINITION
Sulfadimidine Injection is a sterile solution of sulfadimidine sodium in Water for Injections free from dissolved air. It is prepared by the interaction of Sulfadimidine and Sodium Hydroxide.
The injection complies with the requirements stated under Parenteral Preparations and with the following requirements.
Content of sulfadimidine sodium, C12H13N4NaO2S
95.0 to 105.0% of the stated amount.
IDENTIFICATION
A. Acidify a volume containing
B. The residue obtained in test A yields the reaction characteristic of primary aromatic amines, Appendix VI, producing a bright orange-red precipitate.
TESTS
Alkalinity
pH, 10.0 to 11.0, Appendix V L.
Colour of solution
An injection containing
Related substances
Carry out the method for thin-layer chromatography, Appendix III A, using silica gel H as the coating substance and a mixture of 18 volumes of 10M ammonia and 90 volumes of butan-1-ol as the mobile phase. Apply separately to the plate 10 µl of each of the following solutions. For solution (1) use the injection being examined diluted with water to contain 0.20% w/v of sulfadimidine sodium. Solution (2) contains 0.0020% w/v of sulfanilamide in a mixture of 1 volume of 13.5M ammonia and 9 volumes of ethanol (96%). After removal of the plate, heat it at 105° for 10 minutes and spray with a 0.1% w/v solution of 4-dimethylaminobenzaldehyde in ethanol (96%) containing 1% v/v of hydrochloric acid. Any secondary spot in the chromatogram obtained with solution (1) is not more intense than the spot in the chromatogram obtained with solution (2) (1%).
ASSAY
Dilute a volume containing
STORAGE
Sulfadimidine Injection should be protected from light.
LABELLING
The strength is stated as the amount of sulfadimidine sodium in a suitable dose-volume.
Sulfadimidine Tablets
DEFINITION
Sulfadimidine Tablets contain Sulfadimidine.
The tablets comply with the requirements stated under Tablets and with the following requirements.
Content of sulfadimidine, C12H14N4O2S
95.0 to 105.0% of the stated amount.
IDENTIFICATION
A. Triturate a quantity of the powdered tablets containing
B. In the test for Related substances, the principal spot in the chromatogram obtained with solution (2) corresponds to that in the chromatogram obtained with solution (4).
C. The residue obtained in test A yields the reaction characteristic of primary aromatic amines, Appendix VI, producing a bright orange-red precipitate.
Related substances
Carry out the method for thin-layer chromatography, Appendix III A, using silica gel GF254 as the coating substance and a mixture of 3 volumes of 6M ammonia, 5 volumes of water , 40 volumes of nitromethane and 50 volumes of 1,4-dioxan as the mobile phase. Apply separately to the plate 5 µl of each of the following solutions. For solution (1) extract a quantity of the powdered tablets containing
ASSAY
Weigh and powder 20 tablets. Dissolve a quantity of the powder containing
STORAGE
Sulfadimidine Tablets should be protected from light.